Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 37th Asia-Pacific Nursing and Medicare Summit Osaka, Japan.

Day 1 :

Keynote Forum

Yasuko Fukaya

Kanto Gakuin University, Japan

Keynote: The importance of living world communication to elderly people requiring long-term care

Time : 10:00-10:40

Asia Nursing 2017 International Conference Keynote Speaker Yasuko Fukaya photo
Biography:

Yasuko Fukaya has completed her PhD at 1999 from Tokyo University, Japan. She is Professor, department of Home Care Nursing, at Kanto Gakuin University, Japan.

Abstract:

In nursing, communication is essential for nursing practice and its importance is well known from the viewpoint of the quality of care. However, in communication studies associated with medical care and nursing, how has the importance been examined? Through overview of the definition and the contents of studies on patient-centered communication as well as therapeutic communication, clinical/medical communication and health communication, it was found that previous communication studies focused on medical needs or nursing needs of patients or users. Communication is regarded as a means to solve the problems related to such needs, of which scheme has been examined and the outcome has been evaluated. The concept underlying this trend is that the aim of communication between health professionals and patients is different from daily conversation. To address patients in acute or chronic stage and people requiring disease prevention and health promotion, these studies are very important indeed. However, for the elderly, especially the persons who are forced to be hospitalized in an institution for long term and the patients in end-of-life, the ideal communication should be examined, taking account of the intention of communication for a human as the social existence. According to our previous studies, the mean speech time of the institutionalized elderly requiring long-term care was as extremely short as four minutes, which seemed that they were alienated from communication. This study describes the actual situation, background and importance of life world communication in the institutionalized elderly in Japan.

Keynote Forum

Yoshiko Hasebe

Nayoro City University, Japan

Keynote: Onset of dysgeusia in cancer patients receiving outpatient chemotherapy (review)

Time : 10:40-11:20

Asia Nursing 2017 International Conference Keynote Speaker Yoshiko Hasebe photo
Biography:

Yoshiko HASEBE has been working at Nayoro City University School of Health Science. She is a professor of Adult Nursing, and has her expertise in evaluation and passion in improving the nursing practice. She has published many textbooks and DVDs about nursing arts in Japan.

 

Abstract:

Many cancer patients on outpatient chemotherapy complain of dysgeusia. Thus, we searched the literature database of four journals that publish articles related to anti-cancer chemotherapy and taste perception, and reviewed knowledge useful for nursing care of cancer patients.

We found that dysgeusia frequently occurred at a relatively early stage when FOLFOX/FOLFIRI combined with 5-FU, or regimens involving a taxane and related agents were used. The risk of dysgeusia was significantly higher with DTX than with other regimens. This can be explained by the formation of a chelate between 5-FU and zinc, which in turn elevates urinary excretion of zinc, leading to zinc deficiency.

Perception of all basic tastes (saltiness, sweetness, sourness, and umami), except bitterness, tended to be impaired. The frequency of impairment of saltiness perception appeared to be relatively high. Taxanes and related regimens were associated with a high occurrence rate of impairment of umami perception and with severe changes in saltiness perception. Considering the report showing the link between the impairment of saltiness perception and low plasma zinc levels, regimens involving 5-FU is likely to cause disorders in saltiness perception.

Possible causes of dysgeusia attributed to anti-cancer agents include inhibition of taste bud metabolism, lingual nerve disorder and zinc deficiency. It is likely that dysgeusia in patients receiving a taxane and related agents is attributed to peripheral nerve disorders, since these agents do not cause zinc deficiency. Experimental S-1 administration in rats suggested the possibility that dysgeusia is caused by damage to the gustatory nerve but not mucosal epithelia and taste buds.

Regimens involving relatively low doses of 5-FU, for example CMF and FEC therapies, can cause dysgeusia, although it did not appear severe enough to influence patients’ appetite. The frequency of dysgeusia in patients receiving gemcitabine (GEM) was also significantly low.

Break: Networking & Refreshment Break 11:20-11:40 @ Foyer